Hims & Hers Health, Inc. 8-K

What Happened

• Hims & Hers Health, Inc. announced on May 21, 2026 that it issued $402.5 million aggregate principal amount of 0.00% convertible senior notes due June 1, 2032 under an indenture with U.S. Bank Trust Company, N.A. The notes are senior unsecured obligations and will not pay regular interest or accrete principal. The company also entered into privately negotiated capped‑call transactions on May 18–19, 2026 to reduce potential stock dilution related to note conversions.

Key Details

• Principal amount: $402.5 million of convertible senior notes, issued May 21, 2026; maturity June 1, 2032.
• Conversion: initial conversion rate 33.8590 shares per $1,000 principal (≈ $29.53 per share); conversions settled in cash, shares of Class A common stock, or a combination at the company’s election.
• Interest & conversion timing: notes bear no regular interest; conversion generally permitted from March 1, 2032 (earlier only on certain events).
• Redemption & repurchase: company may redeem notes beginning June 6, 2029 if liquidity and price conditions are met; holders can require repurchase for cash if a defined “Fundamental Change” occurs.
• Security & priority: notes are senior unsecured, equal in right of payment with other senior unsecured debt, effectively subordinated to secured debt and structurally subordinated to liabilities of subsidiaries.
• Capped‑call transactions: entered May 18–19, 2026 with several banks to offset dilution/cash settlement exposure; cost ≈ $36.7 million; initial cap price ≈ $50.15 per share (about 125% premium to May 18, 2026 closing price).

Why It Matters

• Financing and dilution: the transaction raises $402.5M of funding without periodic interest payments, but creates potential future dilution if notes convert into Class A shares (conversion price ≈ $29.53). The capped‑call purchases reduce—but do not eliminate—dilution up to a capped price, at a material upfront cost ($36.7M).
• Balance sheet and investor considerations: these notes increase the company’s outstanding senior unsecured obligations and change capital structure (senior unsecured debt that is structurally subordinated to subsidiary liabilities). Investors should watch HIMS share price vs. the conversion price, redemption windows beginning 2029, and any Fundamental Change events that could trigger repurchase rights or earlier conversions.

Exhibits filed with the 8‑K include the indenture, note certificate form, and confirmations for the capped‑call transactions.